Corona: One dose of the Cholera Vaccine is Rnough to Defeat the Plague, Research Reports

WASHINGTON - One dose of antibiotics is enough to defeat the world's coronavirus coronavirus.The second dose has no significant benefits.

This is the result of a study conducted in the United States.The findings are published in the medical journal Science Immunology.

University of Pennsylvania School of Medicine

Research from the University of Pennsylvania School of Medicine says that a single dose of the vaccine has been shown to be sufficient for effective antibodies to those who defeat Code 19.

Research has shown that in people who have never been exposed to code 19.The immune response is activated only after two doses of the vaccine.

The medical research involved people using mRNA vaccines and aimed to tailor future vaccine use strategies.

Research has shown that the memory B cell response after vaccination in people with the first disease is different from those with code 19 protection.

According to experts, research on mRNA vaccines in the past has focused more on antibodies than memory bell cells.Although memory beel cells are a solid factor in predicting future antibody reactions.

The study recruited 44 healthy people who would be vaccinated with Biotech / Pfizer or the modern vaccine.

Eleven of the people selected for the study had previously been victims of Code 19.

The researchers analyzed the immune response before and after the vaccine dose by taking blood samples from these individuals for research.

The study found that those who survived the code and those who were exposed to the vaccine had different immune responses to the vaccine.

The results also showed that a single dose of the vaccine is enough to trigger a full-fledged immune response for people who have contracted code 19.

According to experts, the main reason for this is that their primary immune response to the virus is already strong due to the disease.Whereas those who are protected by COD 19 have such a strong immune response to two doses of the vaccine See you later.

The study also found that one dose of the vaccine was sufficient for a strong immune response in people who defeated code 19 against the South African strain of the corona virus and the D614G mutation.

The study also analyzed the side effects of the vaccine on 32 people who survived the code.

The researchers found that people experienced symptoms such as fever, chills, headache and fatigue after a single dose of the vaccine.

Hemorrhage cases: Denmark bans the use of the AstraZeneca vaccine

There will now be more extensive research by experts to determine the need for one or two doses of the vaccine and to determine how long the effect of the vaccine can last.